Abstract: Anti-vascular endothelial growth factor (anti-VEGF) therapy, such as Bevacizumab, treats colorectal, lung, kidney and breast cancer patients. In 2018, it was approved for treating ovarian ...
A more accurate condition name has the potential to foster better care. In medicine, names of diseases have been changed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback